Financials StemGen, Inc.

Equities

SGNI

US85858B1098

Internet Services

Market Closed - OTC Markets 09:35:56 2023-12-12 am EST 5-day change 1st Jan Change
0.1 USD -.--% Intraday chart for StemGen, Inc. -.--% -.--%

Valuation

Fiscal Period: June 2019 2020 2021
Capitalization 1 47.69 36.34 45.67
Enterprise Value (EV) 1 48.25 37.04 46.48
P/E ratio -60.3 x -158 x -105 x
Yield - - -
Capitalization / Revenue 2,162,176,852 x 1,878,209,302 x 1,171,027,256 x
EV / Revenue 2,187,584,958 x 1,913,983,669 x 1,191,820,333 x
EV / EBITDA -263,413,956 x -776,476,173 x -353,610,147 x
EV / FCF 78,073,046 x 575,730,382 x 1,788,143,148 x
FCF Yield 0% 0% 0%
Price to Book -54.5 x -33.1 x -34.1 x
Nbr of stocks (in thousands) 45,422 45,429 45,670
Reference price 2 1.050 0.8000 1.000
Announcement Date 11/19/19 10/9/20 10/15/21
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021
Net sales - 0.0221 0.0194 0.039
EBITDA - -0.1832 -0.0477 -0.1314
EBIT 1 -0.012 -0.2432 -0.0671 -0.2439
Operating Margin - -1,102.48% -346.61% -625.45%
Earnings before Tax (EBT) 1 -0.012 -0.4255 -0.2308 -0.4331
Net income 1 -0.012 -0.4255 -0.2308 -0.4331
Net margin - -1,929.05% -1,192.62% -1,110.62%
EPS - -0.0174 -0.005079 -0.009498
Free Cash Flow - 0.6181 0.0643 0.026
FCF margin - 2,801.97% 332.44% 66.65%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 2/1/19 11/19/19 10/9/20 10/15/21
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: Juni 2018 2019 2020 2021
Net Debt 1 - 0.56 0.69 0.81
Net Cash position 1 0.02 - - -
Leverage (Debt/EBITDA) - -3.059 x -14.51 x -6.169 x
Free Cash Flow - 0.62 0.06 0.03
ROE (net income / shareholders' equity) - 202% 23.5% 35.7%
ROA (Net income/ Total Assets) - -35.4% -10.6% -38.2%
Assets 1 - 1.201 2.167 1.135
Book Value Per Share 2 0.0900 -0.0200 -0.0200 -0.0300
Cash Flow per Share 2 0 0 0 0
Capex - - - -
Capex / Sales - - - -
Announcement Date 2/1/19 11/19/19 10/9/20 10/15/21
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SGNI Stock
  4. Financials StemGen, Inc.